Navigation Links
SfN releases 'Best Practices for Protecting Researchers and Research'
Date:2/6/2008

Although they pursue crucial research and are required to operate within established regulatory and animal-care frameworks, these investigators face stalking, harassment, and physical assault on their homes. SfN members reported more attacks in the first six months of 2007 than in the five year period from 1999 to 2003.

The continuing intimidation and threats of violence to which researchers have been subjected are beyond the bounds of acceptable discourse and debate, said Jeffrey Kordower, PhD, Chair of the SfN Committee on Animals in Research. In recognition of that fact, the U.S. Congress passed the Animal Enterprise Terrorism Act to prohibit such action, and we now urge universities to add their efforts to ensure that researchers have a safe environment in which to pursue their vital work.

The responsible and humane use of animals in research has been an indispensable part of the health and medical revolution that is treating and curing crippling conditions that affect millions in North America and more around the globe. Disorders like Alzheimers and Parkinsons diseases, paralysis, addiction, and depression cause untold hardship for countless families and drain billions from economies annually. Moreover, it has been repeatedly shown that the American public supports the responsible use of animals to conduct research, and overwhelmingly rejects animal rights extremism.


'/>"/>

Contact: Sara Harris
sharris@sfn.org
202-962-4000
Society for Neuroscience
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CAHI Releases Updated Health Insurance Mandates in the States
2. Heating Plastic Bottles Releases Potentially Harmful Chemical
3. DrScore.com Releases Annual Report Card on Patient Satisfaction in the U.S.
4. CEL-SCI Corporation Releases Letter to Shareholders
5. NASA Releases Findings of Astronaut Survey
6. TABS Group Releases Intriguing Voting Trends Based on Vitamin and Supplement Usage: Republicans More Likely to Use Supplements
7. AHRQ Releases Consumer Financial Incentives Guide for Employers and Other Health Care Purchasers
8. NHCAA Releases Fraud Fighters Handbook Outlining Strategies to Protect the Public Against Health Care Fraud
9. National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment
10. Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver
11. T.G.I. Fridays(R) Restaurants Releases 2008 Food-Related Resolutions Survey Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... advanced Technology Center helps companies develo...y available to the lab allows it to work in a vari... relating to cleaning parts, process development, ...s) December 5, 2009 -- Midbrook, Inc , a Jackson,...gy center laboratory that performs a wide variety ...
(Date:12/4/2009)...ent Trust Inc. (NYSE: CRE ) ("Care" or the "Com... has declared a dividend of $0.17 per share of com..., 2009 to common shareholders of record on Decembe... Care Investment Trust Inc. is a real estate inves...related real estate and commercial mortgage debt. ...
(Date:12/4/2009)...lthcare Trust of America, Inc. ("HTA"), a self-man...nounced the execution of a purchase and sale agree...rtfolio located in San Angelo, Texas, Corsicana, T...0,500,000. The closing of the acquisition is subj... ,, The approximately 92,500 square foot portfolio...
(Date:12/4/2009)...se to the U.S. Justice Department Drug Enforcement...methyltestosterone, and 19-nor-4,9(10)-androstadie...ed Substances Act (CSA), John Gay, executive direc...PA), the oldest and largest trade association rep...upplements and other natural products, issued the ...
(Date:12/4/2009)...re recruited annually to participate in clinical t... Protection (AHRP), and most will be compensated f...ns view payments to volunteers as compensation for...ial risks related to participating in the experime...very different view of clinical trial compensation...
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2
...are unregulated and could be dangerous, agency say...- U.S. health officials warned Wednesday about so ... (BHRT) drugs, an increasing popular alternative t...t of them Internet-based, saying that claims touti...
...nts, needs from product design and development thr...AN FRANCISCO, Jan. 9 Hiemstra Product Development..., announced today that it has,received Food and Dr...edical devices in its 750 sq. ft., class 10,000,CE...
... 9 TeamStaff, Inc.,(Nasdaq: TSTF ) a national pr...ervices, today announced that on January 4, 2008, ...Nasdaq Stock Market ("Nasdaq"),indicating that Tea...aff informing it that for 30 consecutive business,...
...steroids, insulin don,t combat mortality , ...tudies on the treatment of septic shock question t...roids, intensive insulin therapy or with the synth...found no improvement in survival rates. , The seco...
...few weeks since you made that New Years resolution...ns to skip days maybe even weeks. , You know al... to the weight loss, which would obviously be nice...TV instead of going for a short jog is just too gr...
...n. 9 The 11th annual LSU,Health Care Services Div...led "Eliminating Disparities and Improving Access ..., 2008, at the Holiday Inn,Select, 4728 Constituti...e presenters will show how redesign and,improvemen...
Other Medicine News:Health News:FDA Warns Against Bio-Identical Hormone Therapy 2Health News:FDA Warns Against Bio-Identical Hormone Therapy 3Health News:Hiemstra Approved to Manufacture Medical Devices in New CER 2Health News:TeamStaff Receives Nasdaq Determination Letter 2Health News:TeamStaff Receives Nasdaq Determination Letter 3Health News:Standard Septic Shock Treatments Ineffective 2Health News:Standard Septic Shock Treatments Ineffective 3Health News:Standard Septic Shock Treatments Ineffective 4Health News:Exercising judgment: The psychology of fitness 2Health News:Exercising judgment: The psychology of fitness 3Health News:Exercising judgment: The psychology of fitness 4Health News:Exercising judgment: The psychology of fitness 5Health News:Exercising judgment: The psychology of fitness 6Health News:Exercising judgment: The psychology of fitness 7Health News:Exercising judgment: The psychology of fitness 8Health News:Exercising judgment: The psychology of fitness 9Health News:Exercising judgment: The psychology of fitness 10Health News:LSU Forum Examines Health-Care Disparities and Access to Care 2
(Date:12/4/2009)...emistry World recently highlighted a new report ...ufacturers of America ( PhRMA ) that identifies 9...DS and related conditions. ,, The report found t...ines and 54 antivirals. These drugs are either in ...U.S. Food and Drug Administration ( FDA ). ,, &quo...
(Date:12/4/2009)...e, Inc. (NYSE Amex: PIP ), a biodefense company d...al and chemical threats, announced today that the ...ting the effectiveness of Valortim® in an inh...W) rabbit. The data are being presented during an...edical Countermeasures Enterprise (PHEMCE) Stakeho...
(Date:12/4/2009)...rthoAccel Technologies, Inc., developers of the A... to enhance orthodontics, announced the availabili...by PennWell Corporation , a leader in professiona...e and dentistry. The course focuses on patient vi...tment biomechanics, factors that increase treatmen...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4LSUHSC research helps link schizophrenia to specific DNA region 9175 1LSUHSC research helps link schizophrenia to specific DNA region 9175 2UCI Medical Affiliates Inc s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 51103 1UCI Medical Affiliates Inc s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 51103 2UCI Medical Affiliates Inc s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 51103 3UCI Medical Affiliates Inc s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 51103 4Telerent Leasing Corporation Recognized with Monitors Top 100 Award 51098 1Telerent Leasing Corporation Recognized with Monitors Top 100 Award 51098 2
...E)--May 17, 2007 - BioLineRx Ltd. (TASE:,BLRX), Is... today,that abstracts containing data from its suc...1020, first in class GABA-enhanced,antipsychotic f...ted for poster presentations at three leading scie...the following,conferences:, -- Society of Biologic...
...ed at 9th International Symposium on,Myelodysplast...e/ -- New updated results,from a pivotal Phase II ...rable blood cancer known as myelodysplastic syndro...rom the H. Lee Moffitt,Cancer Center & Researc... MDS currently taking place in Florence, Italy.,Br...
Other Medicine Technology:BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 2Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 3
Lambert Rake Membrane Spatula
Olk Angled Retinal Spatula - 110 Degree
Castroviejo Cyclodialysis Spatula
Cleasby Iris Spatula
Medicine Products: